Cancer News and Research

Latest Cancer News and Research

In states not expanding Medicaid, hospitals face a squeeze as federal funds dry up

The New York Times examines the dilemma for some safety-net hospitals that will not see a drop in the uninsured but will lose federal money that used to help pay for those patients.

12 Nov 2013

Broom offers tips to help children cope with parent's deployment

While in the Navy, Broom regularly saw children of deployed parents in military pediatric offices. His biggest take away message from that experience is that families who are most successful at navigating deployment are those who plan and communicate.

12 Nov 2013

Lifestyle changes boost QoL during long-term ADT

A study shows that a lifestyle intervention, involving an exercise program and dietary advice, improves disease-specific quality of life in sedentary men with advanced prostate cancer who are receiving long-term androgen-deprivation therapy.

11 Nov 2013

Pneumococcal pneumonia linked to lung cancer risk

Pneumococcal pneumonia is significantly associated with risk for lung cancer, show findings from a national study in Taiwan.

11 Nov 2013

Delmar Pharmaceuticals announces quarterly update, strengthens intellectual property portfolio

As of September 30, 2013, Delmar Pharmaceuticals has cash and equivalents of approximately $5.2 million and its working capital balance is in line with its expectations.

11 Nov 2013

Specialist lung cancer nurses could aid treatment

A University research study has found that specialist lung cancer nurses could be putting patients in a stronger and healthier position to cope with the rigorous course of treatment that they undergo.

From Sheffield Hallam University 11 Nov 2013

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

NanoViricides, Inc. announced today that the European Medicines Agency, has awarded orphan drug designation to DengueCide, the Company's drug candidate for the treatment of dengue and dengue hemorrhagic fever.

11 Nov 2013

First Edition: November 11, 2013

Today's headlines include reports about how Republicans are positioning themselves to capitalize on the health law's implementation difficulties in the upcoming election season.

11 Nov 2013

Patrys initiates IST of PAT-SM6 in combination with carfilzomib in multiple myeloma patients

Patrys Limited, a clinical stage biotechnology company has today announced that it is initiating an investigator-sponsored trial evaluating the effectiveness of Patrys’ lead anti-cancer drug PAT-SM6 in combination with carfilzomib, in patients with relapsed and refractory multiple myeloma.

11 Nov 2013

Targeted radiotherapy could offer viable alternative to current procedures for breast cancer

Two new studies, published in The Lancet and The Lancet Oncology, show that targeted radiotherapy delivered during surgery could offer a viable alternative to current procedures – which require women to attend daily radiotherapy sessions for weeks after surgery – for some women undergoing surgery for early breast cancer.

11 Nov 2013

Nutranomics provides update on GenEpic prostate cancer human clinical study

Nutranomics, Inc. is pleased to provide this update regarding the GenEpic prostate cancer human clinical study that is currently underway. Nutranomics has previously announced a non-binding Letter of Intent with Genesar Nutraceuticals, LLC with the intent of completing a licencing agreement to market and distribute GenEpic globally.

11 Nov 2013

GW Pharmaceuticals starts Phase 1b/2a clinical trial for Recurrent Glioblastoma Multiforme

GW Pharmaceuticals plc a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today it has commenced a Phase 1b/2a clinical trial for the treatment of Recurrent Glioblastoma Multiforme.

11 Nov 2013

Viewpoints: Campaigning won't help solve health care problems; health law sought 'sturdier safety net;' court's decision on contraception benefit 'goes wrong way'

The Obamacare Web site doesn't work. Hundreds of thousands of insured Americans are seeing their plans summarily terminated. Millions more face the same prospect next year. Confronted with a crisis of governance, how does President Obama respond? He campaigns (Charles Krauthammer, 11/7).

11 Nov 2013

BioInvent International receives US patent for drug discovery technology F.I.R.S.T.

BioInvent International AB today announces that it has been granted a US patent for its antibody and concomitant target discovery technology F.I.R.S.T.

11 Nov 2013

CTCA doctor presents cutting-edge treatments for cancer patients to medical colleagues

Walter Quan, Jr., MD Chief of Medical Oncology and Director of Immunotherapy at Cancer Treatment Centers of America- Western Regional Medical Center is presenting new findings that are showing a major benefit to cancer patients.

11 Nov 2013

Research roundup: Pricing and the SHOP exchange; health use in rural vs. urban areas; the health law and AIDS care

Each week, KHN compiles a selection of recently released health policy studies and briefs.

11 Nov 2013

Treatment with rheumatoid arthritis drug saved transplanted kidney and achieved remission

A drug approved for the treatment of rheumatoid arthritis may also turn out to be the first targeted therapy for one of the most common forms of kidney disease, a condition that almost inevitably leads to kidney failure.

11 Nov 2013

Women with poor financial status more likely to delay in seeking care for breast cancer

Researchers who sought to determine why breast cancers are more deadly in young women found that only a minority of young women experience long delays between the time they detect a breast abnormality and the time they receive a diagnosis, but delays in seeking care are more common in women with fewer financial resources.

11 Nov 2013

Simple dot test could help doctors gauge extent of dopamine loss in Parkinson's patients

A pilot study by a multi-disciplinary team of investigators at Georgetown University suggests that a simple dot test could help doctors gauge the extent of dopamine loss in individuals with Parkinson's disease. Their study is being presented at Neuroscience 2013, the annual meeting of the Society for Neuroscience.

11 Nov 2013

Study suggests that therapies targeting KDM2A may benefit subset of NSCLS patients

Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer deaths worldwide. Current therapies that target cellular kinases have been effective for some patients: however, many individuals with NSCLS do not respond.

11 Nov 2013

Cancer News and Research

Latest Cancer News and Research

In states not expanding Medicaid, hospitals face a squeeze as federal funds dry up

Broom offers tips to help children cope with parent's deployment

Lifestyle changes boost QoL during long-term ADT

Pneumococcal pneumonia linked to lung cancer risk

Delmar Pharmaceuticals announces quarterly update, strengthens intellectual property portfolio

Specialist lung cancer nurses could aid treatment

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

First Edition: November 11, 2013

Patrys initiates IST of PAT-SM6 in combination with carfilzomib in multiple myeloma patients

Targeted radiotherapy could offer viable alternative to current procedures for breast cancer

Nutranomics provides update on GenEpic prostate cancer human clinical study

GW Pharmaceuticals starts Phase 1b/2a clinical trial for Recurrent Glioblastoma Multiforme

Viewpoints: Campaigning won't help solve health care problems; health law sought 'sturdier safety net;' court's decision on contraception benefit 'goes wrong way'

BioInvent International receives US patent for drug discovery technology F.I.R.S.T.

CTCA doctor presents cutting-edge treatments for cancer patients to medical colleagues

Research roundup: Pricing and the SHOP exchange; health use in rural vs. urban areas; the health law and AIDS care

Treatment with rheumatoid arthritis drug saved transplanted kidney and achieved remission

Women with poor financial status more likely to delay in seeking care for breast cancer

Simple dot test could help doctors gauge extent of dopamine loss in Parkinson's patients

Study suggests that therapies targeting KDM2A may benefit subset of NSCLS patients

Understanding the DNA Damage Response in Innate Immunity eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Newsletters you may be interested in